177 related articles for article (PubMed ID: 35228815)
21. Prognosis Analysis and Validation of m
Lin S; Xu H; Zhang A; Ni Y; Xu Y; Meng T; Wang M; Lou M
Front Oncol; 2020; 10():541401. PubMed ID: 33123464
[TBL] [Abstract][Full Text] [Related]
22. Analysis and validation of aging-related genes in prognosis and immune function of glioblastoma.
Mu J; Gong J; Shi M; Zhang Y
BMC Med Genomics; 2023 May; 16(1):109. PubMed ID: 37208656
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive analysis of the prognosis and immune infiltrates for the BET protein family reveals the significance of BRD4 in glioblastoma multiforme.
Ye Y; Zhong W; Qian J; Zhang J; Xu T; Han R; Han J; Wang C; Song L; Zeng X; Wang H
Front Cell Dev Biol; 2023; 11():1042490. PubMed ID: 36711038
[No Abstract] [Full Text] [Related]
24. A 63 signature genes prediction system is effective for glioblastoma prognosis.
Zhang Y; Xu J; Zhu X
Int J Mol Med; 2018 Apr; 41(4):2070-2078. PubMed ID: 29393370
[TBL] [Abstract][Full Text] [Related]
25. Identification of
Lin H; Yang Y; Hou C; Zheng J; Lv G; Mao R; Xu P; Chen S; Zhou Y; Wang P; Zhou D
Genet Test Mol Biomarkers; 2021 May; 25(5):334-345. PubMed ID: 33970702
[No Abstract] [Full Text] [Related]
26. Identification of Gender-Specific Molecular Differences in Glioblastoma (GBM) and Low-Grade Glioma (LGG) by the Analysis of Large Transcriptomic and Epigenomic Datasets.
Khan MT; Prajapati B; Lakhina S; Sharma M; Prajapati S; Chosdol K; Sinha S
Front Oncol; 2021; 11():699594. PubMed ID: 34621669
[TBL] [Abstract][Full Text] [Related]
27. Establish six-gene prognostic model for glioblastoma based on multi-omics data of TCGA database.
Lei CG; Jia XY; Sun WJ
Yi Chuan; 2021 Jul; 43(7):665-679. PubMed ID: 34284982
[TBL] [Abstract][Full Text] [Related]
28. Immune infiltration landscape and immune-marker molecular typing of pulmonary fibrosis with pulmonary hypertension.
Cai H; Liu H
BMC Pulm Med; 2021 Nov; 21(1):383. PubMed ID: 34823498
[TBL] [Abstract][Full Text] [Related]
29. Analysis of long non-coding RNAs in glioblastoma for prognosis prediction using weighted gene co-expression network analysis, Cox regression, and L1-LASSO penalization.
Liang R; Zhi Y; Zheng G; Zhang B; Zhu H; Wang M
Onco Targets Ther; 2019; 12():157-168. PubMed ID: 30613154
[TBL] [Abstract][Full Text] [Related]
30. SAA1 Expression as a Potential Prognostic Marker of the Tumor Microenvironment in Glioblastoma.
Cao K; Jiang X; Wang B; Ni Z; Chen Y
Front Neurol; 2022; 13():905561. PubMed ID: 35756918
[TBL] [Abstract][Full Text] [Related]
31. Identification of Immune Cell Infiltration and Immune-Related Genes in the Tumor Microenvironment of Glioblastomas.
Huang S; Song Z; Zhang T; He X; Huang K; Zhang Q; Shen J; Pan J
Front Immunol; 2020; 11():585034. PubMed ID: 33193404
[TBL] [Abstract][Full Text] [Related]
32. 9-Gene Signature Correlated With CD8
Yan K; Lu Y; Yan Z; Wang Y
Front Immunol; 2021; 12():622563. PubMed ID: 34220795
[TBL] [Abstract][Full Text] [Related]
33. Establishment and validation of an immune-based prognostic score model in glioblastoma.
Qin Z; Zhang X; Chen Z; Liu N
Int Immunopharmacol; 2020 Aug; 85():106636. PubMed ID: 32534425
[TBL] [Abstract][Full Text] [Related]
34. Identification of Tumor Antigens and Immune Subtypes of Glioblastoma for mRNA Vaccine Development.
Lin H; Wang K; Xiong Y; Zhou L; Yang Y; Chen S; Xu P; Zhou Y; Mao R; Lv G; Wang P; Zhou D
Front Immunol; 2022; 13():773264. PubMed ID: 35185876
[TBL] [Abstract][Full Text] [Related]
35. A Novel Necroptosis-Related Prognostic Signature of Glioblastoma Based on Transcriptomics Analysis and Single Cell Sequencing Analysis.
Wu Y; Huang Y; Zhou C; Wang H; Wang Z; Wu J; Nie S; Deng X; Sun J; Gao X
Brain Sci; 2022 Jul; 12(8):. PubMed ID: 35892430
[TBL] [Abstract][Full Text] [Related]
36. Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma.
Zhang M; Wang X; Chen X; Zhang Q; Hong J
Front Genet; 2020; 11():363. PubMed ID: 32351547
[TBL] [Abstract][Full Text] [Related]
37. The molecular feature of macrophages in tumor immune microenvironment of glioma patients.
Zhang H; Luo YB; Wu W; Zhang L; Wang Z; Dai Z; Feng S; Cao H; Cheng Q; Liu Z
Comput Struct Biotechnol J; 2021; 19():4603-4618. PubMed ID: 34471502
[TBL] [Abstract][Full Text] [Related]
38. Identification of HOXD10 as a Marker of Poor Prognosis in Glioblastoma Multiforme.
Li Y; Ma K; Xie Q; Zhang X; Zhang X; Chen K; Kong L; Qian R
Onco Targets Ther; 2021; 14():5183-5195. PubMed ID: 34737577
[TBL] [Abstract][Full Text] [Related]
39. Quiescent stem cell marker genes in glioma gene networks are sufficient to distinguish between normal and glioblastoma (GBM) samples.
Mukherjee S
Sci Rep; 2020 Jul; 10(1):10937. PubMed ID: 32616845
[TBL] [Abstract][Full Text] [Related]
40. Four specific biomarkers associated with the progression of glioblastoma multiforme in older adults identified using weighted gene co-expression network analysis.
Yang Y; Chu L; Zeng Z; Xu S; Yang H; Zhang X; Jia J; Long N; Hu Y; Liu J
Bioengineered; 2021 Dec; 12(1):6643-6654. PubMed ID: 34516348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
